Skip to main navigation Skip to search Skip to main content

Invasive Fungal Pneumonia in Immunocompromised Patients

  • Myrna C.B. Godoy*
  • , Hanna R. Ferreira Dalla Pria
  • , Mylene T. Truong
  • , Girish S. Shroff
  • , Edith M. Marom
  • *Corresponding author for this work
  • University of Texas MD Anderson Cancer Center

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations

Abstract

Fungal pneumonia is the most frequent presentation of invasive fungal infections (IFIs) in patients with hematologic malignancies (HM) and hematopoietic stem cell transplantation (HSCT) recipients. The most common causes include Aspergillus, Mucor, Fusarium, and Candida species. The high incidence and high morbidity and mortality rate of fungal pneumonias in HM/HSCT populations arise from severe immune dysfunction that may be caused by both the underlying disease and/or its treatment. CT is routinely used when pulmonary complications are suspected after HSCT. Appropriate image interpretation of the posttransplant patient requires a combination of pattern recognition and knowledge of the clinical setting. In this article, we provide an overview of the clinical manifestations and CT imaging features of the most common invasive fungal pneumonias (IFPs) seen in severely immunosuppressed hosts.

Original languageEnglish
Pages (from-to)497-506
Number of pages10
JournalRadiologic Clinics of North America
Volume60
Issue number3
DOIs
StatePublished - May 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adverse effects
  • Computed X-ray tomography
  • Fungal pneumonia
  • Hematopoietic stem cell transplantation
  • Pulmonary aspergillosis
  • Pulmonary candidiasis
  • Pulmonary mucormycosis

Fingerprint

Dive into the research topics of 'Invasive Fungal Pneumonia in Immunocompromised Patients'. Together they form a unique fingerprint.

Cite this